Oh where oh where is OH? Measuring the elusive hydroxyl radical in the atmosphere using laser-induced fluorescence

The hydroxyl radical (OH) plays a central role in the chemistry of the atmosphere. In addition to controlling the lifetimes of many trace gases important to issues of global climate change and stratospheric ozone depletion, the OH radical initiates the oxidation of carbon monoxide and volatile organic compounds which in the presence of nitrogen oxides can lead to the production of ground-level ozone and secondary organic aerosols, the primary components of photochemical smog. Accurate measurements of OH radical concentrations in the atmosphere can provide critical tests of our understanding of atmospheric chemistry and ground-level ozone production in urban and rural areas. Because of its high reactivity, mixing ratios of OH in the atmosphere are extremely low (typically less than 0.1 parts per trillion) and its chemical lifetime very short (less than 1 second). As a result, measurements of OH present a serious analytical challenge, especially on the timescale necessary to test our understanding of the fast photochemistry of the atmosphere. This presentation will describe the Indiana University laser-induced fluorescence instrument for the sensitive detection of OH radicals in the atmosphere, including recent results from several measurement campaigns in both urban and rural environments

MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys

MDAN-21, , a bivalent opioid ligand containing a mu-opioid receptor agonist (derived from oxymorphone) linked to the delta-opioid receptor antagonist (related to naltrindole) by a spacer of 21 atoms, was reported to have potent analgesic properties in mice. Tolerance, physical dependence, and conditioned place preference were not evident in that species. The finding that bivalent ligands in this series, with spacers 19 atoms or greater, were devoid of tolerance and dependence led to the proposal that MDAN-21 targets heteromeric mu-delta-opioid receptors. The present study focused on its effects in nonhuman primates (Macaca mulatta), a species with a physiology and behavioral repertoire not unlike humans. With regard to opioids, this species usually better predicts clinical outcomes. MDAN-21 substituted for morphine in morphine-dependent monkeys in the remarkably low dose range 0.006–0.032 mg/kg, subcutaneously. Although MDAN-21 failed to produce reliable thermal analgesia in the dose range 0.0032–0.032 mg/kg, intramuscularly, it was active in the same dose range and by the same route of administration, in the capsaicin-induced thermal allodynia assay. The results suggest that MDAN-21 may be useful in the treatment of opioid dependence and allodynia. The data provide additional evidence that opioid withdrawal is associated with sensitized pain

Charge Fluctuations on Membrane Surfaces in Water

We generalize the predictions for attractions between over-all neutral surfaces induced by charge fluctuations/correlations to non-uniform systems that include dielectric discontinuities, as is the case for mixed charged lipid membranes in an aqueous solution. We show that the induced interactions depend in a non-trivial way on the dielectric constants of membrane and water and show different scaling with distance depending on these properties. The generality of the calculations also allows us to predict under which dielectric conditions the interaction will change sign and become repulsive

The first GeV flare of the radio-loud narrow-line Seyfert 1 galaxy PKS 2004-447

On 2019 October 25, the Fermi-Large Area Telescope observed the first gamma-ray flare from the radio-loud narrow-line Seyfert 1 (NLSy 1) galaxy PKS 2004$-$447 ($z=0.24$). We report on follow-up observations in the radio, optical-UV, and X-ray bands that were performed by ATCA, the Neil Gehrels Swift observatory, XMM-Newton, and NuSTAR, respectively, and our multi-wavelength analysis. We study the variability across all energy bands and additionally produce $\gamma$-ray light curves with different time binnings to study the variability on short timescales during the flare. We examine the X-ray spectrum from 0.5$-$50 keV by describing the spectral shape with an absorbed power law. We analyse multi-wavelength datasets before, during, and after the flare and compare these with a low activity state of the source by modelling the respective SEDs with a one-zone synchrotron inverse Compton radiative model. Finally, we compare our results to gamma-ray flares previously observed from other $\gamma$-loud NLSy 1 galaxies. At gamma-ray energies (0.1$-$300 GeV) the flare reached a total maximum flux of $(2.7\pm0.6)\times10^{-6}$~ph~cm$^{-2}$~s$^{-1}$ in 3-hour binning. With a photon index of $\Gamma_{0.1-300\mathrm{GeV}}=2.42\pm0.09$ during the flare, this corresponds to an isotropic gamma-ray luminosity of $(2.9\pm0.8)\times10^{47}\,\mathrm{erg}\,\mathrm{s}^{-1}$. The $\gamma$-ray, X-ray, and optical-UV light curves covering the end of September to the middle of November show significant variability, and we find indications for flux-doubling times of $\sim 2.2$~hours at $\gamma$-ray energies. During the flare, the SED exhibits large Compton dominance. While the increase in the optical-UV range can be explained by enhanced synchrotron emission, the elevated $\gamma$-ray flux can be accounted for by an increase in the bulk Lorentz factor of the jet, similarly observed for flaring gamma-ray blazars.Comment: 17 pages, 7 figures. Accepted for publication in Astronomy & Astrophysic

Synthesis of 3-D coronal-solar wind energetic particle acceleration modules

1. Introduction Acute space radiation hazards pose one of the most serious risks to future human and robotic exploration. Large solar energetic particle (SEP) events are dangerous to astronauts and equipment. The ability to predict when and where large SEPs will occur is necessary in order to mitigate their hazards. The Coronal-Solar Wind Energetic Particle Acceleration (C-SWEPA) modeling effort in the NASA/NSF Space Weather Modeling Collaborative [Schunk, 2014] combines two successful Living With a Star (LWS) (http://lws. gsfc.nasa.gov/) strategic capabilities: the Earth-Moon-Mars Radiation Environment Modules (EMMREM) [Schwadron et al., 2010] that describe energetic particles and their effects, with the Next Generation Model for the Corona and Solar Wind developed by the Predictive Science, Inc. (PSI) group. The goal of the C-SWEPA effort is to develop a coupled model that describes the conditions of the corona, solar wind, coronal mass ejections (CMEs) and associated shocks, particle acceleration, and propagation via physics-based modules. Assessing the threat of SEPs is a difficult problem. The largest SEPs typically arise in conjunction with X class flares and very fast (\u3e1000 km/s) CMEs. These events are usually associated with complex sunspot groups (also known as active regions) that harbor strong, stressed magnetic fields. Highly energetic protons generated in these events travel near the speed of light and can arrive at Earth minutes after the eruptive event. The generation of these particles is, in turn, believed to be primarily associated with the shock wave formed very low in the corona by the passage of the CME (injection of particles from the flare site may also play a role). Whether these particles actually reach Earth (or any other point) depends on their transport in the interplanetary magnetic field and their magnetic connection to the shock

Differences in BVOC oxidation and SOA formation above and below the forest canopy

Gas-phase biogenic volatile organic compounds (BVOCs) are oxidized in the troposphere to produce secondary pollutants such as ozone (O3), organic nitrates (RONO2), and secondary organic aerosol (SOA). Two coupled zero-dimensional models have been used to investigate differences in oxidation and SOA production from isoprene and α-pinene, especially with respect to the nitrate radical (NO3), above and below a forest canopy in rural Michigan. In both modeled environments (above and below the canopy), NO3 mixing ratios are relatively small (< 0.5 pptv); however, daytime (08:00–20:00 LT) mixing ratios below the canopy are 2 to 3 times larger than those above. As a result of this difference, NO3 contributes 12 % of total daytime α-pinene oxidation below the canopy while only contributing 4 % above. Increasing background pollutant levels to simulate a more polluted suburban or peri-urban forest environment increases the average contribution of NO3 to daytime below-canopy α-pinene oxidation to 32 %. Gas-phase RONO2 produced through NO3 oxidation undergoes net transport upward from the below-canopy environment during the day, and this transport contributes up to 30 % of total NO3-derived RONO2 production above the canopy in the morning (∼ 07:00). Modeled SOA mass loadings above and below the canopy ultimately differ by less than 0.5 µg m−3, and extremely low-volatility organic compounds dominate SOA composition. Lower temperatures below the canopy cause increased partitioning of semi-volatile gas-phase products to the particle phase and up to 35 % larger SOA mass loadings of these products relative to above the canopy in the model. Including transport between above- and below-canopy environments increases above-canopy NO3-derived α-pinene RONO2 SOA mass by as much as 45 %, suggesting that below-canopy chemical processes substantially influence above-canopy SOA mass loadings, especially with regard to monoterpene-derived RONO2

Update on novel pharmacological therapies for osteoarthritis

Osteoarthritis (OA) is a chronic painful arthritis with increasing global prevalence. Current management involves non-pharmacological interventions and commonly used pharmacological treatments that generally have limited analgesic efficacy and multiple side-effects. New treatments are therefore required in order to relieve patient symptoms and disease impact. A number of existing pharmacological therapies have been recently trialled in OA. These include extended-release triamcinolone and conventional disease-modifying anti-rheumatic drugs (DMARDs) used in the management of rheumatoid arthritis; generally the DMARDs have not shown benefit in treating OA. Novel analgesic therapies are in development, including those targeting peripheral pain pathways. Disease-modifying osteoarthritis drugs (DMOADs) target key tissues in the OA pathophysiology process and aim to prevent structural progression; a number of putative DMOADs are in phase II development. There is preliminary evidence of structural improvement with some of these therapies but without concomitant symptom improvement, raising new considerations for future DMOAD trials